-
-
-
-
-
-
-
ANI Pharmaceuticals announces board leadership changes
-
-
-
-
-
-
-
ANI Pharmaceuticals Announces Results from NEW DAY Clinical Trial of ILUVIENĀ® for Use in Patients with Diabetic Macular Edema (DME)
-
-
-
-
-
-
-
ANI Pharma (ANIP) Announces Buyout of Royalty Obligation for ILUVIEN and YUTIQ
-
-
-
-
-
-
-
ANI Pharmaceuticals Reports Record Fourth Quarter and Full-Year 2024 Financial Results and Raises 2025 Guidance
-
-
-
-
-
-
-
ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on ANI Pharmaceuticals (ANIP)
-
-
-
-
-
-
-
ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger
-
1,158,055 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

